Status:
COMPLETED
Comparison of Short-term Sustained-release Opioid in Open Abdominal Urologic Surgeries
Lead Sponsor:
University of Alberta
Conditions:
Pain, Acute
Opioid Use
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The advantage of slow-release opioid allows for less fluctuation in drug (pain killer) levels in the blood and an extended period within the effective range for pain relief. The slow-release opioids h...
Detailed Description
This will be a randomized, double-blind, controlled trial looking at all adult patients undergoing open abdominal urologic surgeries. After assessing the inclusion/exclusion criteria, the patients wil...
Eligibility Criteria
Inclusion
- All adult patients undergoing open abdominal urologic surgeries
- ASA 1-3
Exclusion
- Patient refusal
- history of chronic pain
- allergy to hydromorphone
- cannot swallow tablets
Key Trial Info
Start Date :
May 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05375916
Start Date
May 3 2022
End Date
November 30 2023
Last Update
May 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta Hospital
Edmonton, Alberta, Canada, T6G 2G3